Large-scale testing (Phase 3)Study completedNCT01345682
What this trial is testing
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Who this might be right for
Head and Neck NeoplasmsCarcinoma, Squamous Cell
Boehringer Ingelheim 483